Appendix 2.
Characteristics | Without measures |
With measures |
P value |
---|---|---|---|
N = 267 | N = 332 | ||
Age, year | 51.4 ± 13.6 | 51.3 ± 14.5 | .92 |
Female (%) | 208 (77.9) | 262 (78.9) | .76 |
Race (%) | |||
Black | 6 (2.3) | 6 (1.8) | |
White | 257 (96.3) | 324 (97.6) | .08 |
Other | 4 (1.5) | 4 (0.6) | |
Ethnicity (%) | |||
Hispanic/Latino | 3 (1.1) | 1 (0.3) | .37 |
Insurance (%) | |||
Medicare | 47 (17.6) | 86 (25.9) | |
Medicaid/assistance | 21 (7.9) | 30 (9.0) | .03 |
Commercial | 199 (74.5) | 216 (65.1) | |
Smoking (%) | |||
Current | 16 (6.0) | 22 (6.6) | |
Former | 79 (29.6) | 100 (30.1) | .69 |
Never | 170 (63.7) | 204 (61.5) | |
Comorbidities | |||
Anxiety | 70 (26.8) | 70 (21.2) | .11 |
Chronic obstructive pulmonary disease | 2 (0.8) | 5 (1.5) | .40 |
Coronary artery disease | 16 (6.1) | 24 (7.3) | .58 |
Diabetes | 44 (16.9) | 58 (17.6) | .82 |
Depression | 71 (27.2) | 108 (32.7) | .15 |
High cholesterol | 80 (30.7) | 98 (29.7) | .79 |
Osteoarthritis | 52 (19.9) | 63 (19.1) | .81 |
Sleep apnea | 91 (34.9) | 119 (36.1) | .76 |
Cardiovascular disease | 5 (1.9) | 5 (1.5) | .71 |
Non-alcoholic fatty liver disease | 10 (3.8) | 23 (7.0) | .99 |
Body composition measures | |||
Weight | 118.5 ± 26.1 | 120.9 ± 30.4 | .31 |
Waist circumference | 135.1 ± 91.1 | 130.1 ± 48.4 | .39 |
High waist circumference | 265 (99.3) | 329 (99.1) | .84 |
Sarcopenia status (%) | 127 (47.6) | 158 (47.6) | .99 |
Body mass index, kg/m2 | 42.7 ± 8.2 | 43.4 ± 9.5 | .35 |
Appendicular lean mass, kg | 16.6 ± 4.5 | 16.8 ± 4.8 | .63 |
Fat mass, kg | 58.1 ± 16.3 | 60.0 ± 19.0 | .21 |
Body fat, % | 48.7 ± 6.2 | 49.1 ± 5.9 | .45 |
Visceral adipose tissue, cm | 6.26 ± 3.97 | 6.76 ± 4.82 | .78 |
Skeletal muscle mass | 29.6 ± 7.8 | 29.7 ± 8.2 | .80 |
Excluded individuals consisted of study subjects with at least one functional measure (grip strength, sit-to-stand, 6 minute walk, URICA, WEL-SF, PROMIS) missing in their data. All values presented are mean ± standard deviation, or counts (percent). A P value represents the differences between individuals with and without ALM-defined sarcopenia (<19.75 kg in men; <15.02 kg in women).
Abbreviations: ALM, appendicular lean mass; PROMIS, Patient Reported Outcome Measurement Information Systems; URICA, University of Rhode Island Change Assessment; WEL-SF, Weight Efficacy Short-Form.